Author: Marinaki, Smaragdi; Adamopoulos, Stamatis; Degiannis, Dimitrios; Roussos, Sotirios; Pavlopoulou, Ioanna D.; Hatzakis, Angelos; Boletis, Ioannis N.
Title: Immunogenicity of SARSâ€CoVâ€2 BNT162b2 vaccine in solid organ transplant recipients Cord-id: lrnj3tdw Document date: 2021_5_7
ID: lrnj3tdw
Snippet: Solid organ transplant (SOT) recipients represent a high-risk group for all SARS-COV-2 infection-related adverse outcomes. Therefore, most European countries have established prioritization of SOTrecipients in their vaccination programs. Suboptimal vaccine efficacy to the SARS-COV-2 vaccines is anticipated; however, they have been excluded from vaccination trials. Overall response rates to other vaccines as influenza have demonstrated high, though acceptable, variability.
Document: Solid organ transplant (SOT) recipients represent a high-risk group for all SARS-COV-2 infection-related adverse outcomes. Therefore, most European countries have established prioritization of SOTrecipients in their vaccination programs. Suboptimal vaccine efficacy to the SARS-COV-2 vaccines is anticipated; however, they have been excluded from vaccination trials. Overall response rates to other vaccines as influenza have demonstrated high, though acceptable, variability.
Search related documents:
Co phrase search for related documents- Try single phrases listed below for: 1
Co phrase search for related documents, hyperlinks ordered by date